19/03/2013 by Buildington
AstraZeneca today announced its intention to establish a new global R&D centre and corporate headquarters in Cambridge in the UK by 2016.
AstraZeneca’s global headquarters at Two Kingdom Street has around 350 employees in commercial, global and corporate functions. It is expected that the majority of these roles will move to the new facility in Cambridge, which will become the company’s new global headquarters, or to other sites. The Paddington offices are expected to close by 2016.